These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24887510)

  • 21. Amoxicillin-clavulante as the gold standard empirical therapy of acute bacteria rhinosinusitis.
    Brook I
    Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1367-9. PubMed ID: 23253313
    [No Abstract]   [Full Text] [Related]  

  • 22. Atypical cutaneous tuberculosis in a patient with rheumatoid arthritis treated with infliximab.
    Asano Y; Kano Y; Shiohara T
    Acta Derm Venereol; 2008; 88(2):183-4. PubMed ID: 18311458
    [No Abstract]   [Full Text] [Related]  

  • 23. [Optical neuritis secondary to a rhinosinus disease].
    Santos Lasaosa S; García Arguedas C; Gil Villar MP
    Neurologia; 2010 Oct; 25(8):519-20. PubMed ID: 20965007
    [No Abstract]   [Full Text] [Related]  

  • 24. Bullous skin lesions following infliximab infusion in a patient with rheumatoid arthritis.
    Kent PD; Davis JM; Davis MD; Matteson EL
    Arthritis Rheum; 2002 Aug; 46(8):2257-8; author reply 2259. PubMed ID: 12209539
    [No Abstract]   [Full Text] [Related]  

  • 25. The arthritic fisherman.
    Roddy K; Kao G; Dawn M; Bock J; Riedel D; Gilliam B
    Am J Med; 2008 Apr; 121(4):287-9. PubMed ID: 18374685
    [No Abstract]   [Full Text] [Related]  

  • 26. Disseminated histoplasmosis with colonic ulcers in a patient receiving infliximab.
    Gupta N; Fox CM; Grisolano SW
    Gastrointest Endosc; 2009 Sep; 70(3):597-8. PubMed ID: 19573865
    [No Abstract]   [Full Text] [Related]  

  • 27. What rhinologists and allergists should know about the medico-legal implications of antibiotic use: a review of the literature.
    Poetker DM; Smith TL
    Int Forum Allergy Rhinol; 2015 Feb; 5(2):104-10. PubMed ID: 25332200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of omalizumab in eosinophilic chronic rhinosinusitis patients with asthma.
    Tajiri T; Matsumoto H; Hiraumi H; Ikeda H; Morita K; Izuhara K; Ono J; Ohta S; Ito I; Oguma T; Nakaji H; Inoue H; Iwata T; Nagasaki T; Kanemitsu Y; Ito J; Niimi A; Mishima M
    Ann Allergy Asthma Immunol; 2013 May; 110(5):387-8. PubMed ID: 23622013
    [No Abstract]   [Full Text] [Related]  

  • 29. Associations between fatigue and medication use in chronic rhinosinusitis.
    Bhattacharyya N; Kepnes LJ
    Ear Nose Throat J; 2006 Aug; 85(8):510, 512, 514-5. PubMed ID: 16999057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cryptococcal meningitis in a patient treated with infliximab.
    Muñoz P; Giannella M; Valerio M; Soria T; Díaz F; Longo JL; Bouza E
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):443-6. PubMed ID: 17240111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Executive summary. Sinus and Allergy Health Partnership.
    Otolaryngol Head Neck Surg; 2000 Jul; 123(1 Pt 2):1-4. PubMed ID: 10887345
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety of biologic therapies--an update.
    Keystone EC
    J Rheumatol Suppl; 2005 Mar; 74():8-12. PubMed ID: 15742458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Case of miliary tuberculosis during treatment with infliximab for rheumatoid arthritis].
    Taniguchi H; Izumi S
    Kekkaku; 2008 May; 83(5):431-4. PubMed ID: 18536334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Sinus and Allergy Health Partnership.
    Otolaryngol Head Neck Surg; 2000 Jul; 123(1 Pt 2):5-31. PubMed ID: 10887346
    [No Abstract]   [Full Text] [Related]  

  • 35. Primary cutaneous Nocardia otitidiscaviarum infection in a patient with rheumatoid arthritis treated with infliximab.
    Fabre S; Gibert C; Lechiche C; Jorgensen C; Sany J
    J Rheumatol; 2005 Dec; 32(12):2432-3. PubMed ID: 16331777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodality topical therapy for refractory chronic rhinosinusitis: our experience in thirteen patients with and twelve patients without nasal polyps.
    Shikani AH; Kourelis K; Alqudah MA; Shikani HJ; Cope E; Kirk N; Bergstedt D; Basaraba RJ; Leid JG
    Clin Otolaryngol; 2013 Jun; 38(3):254-8. PubMed ID: 23398898
    [No Abstract]   [Full Text] [Related]  

  • 37. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis.
    Ostör AJ; Chilvers ER; Somerville MF; Lim AY; Lane SE; Crisp AJ; Scott DG
    J Rheumatol; 2006 Mar; 33(3):622-8. PubMed ID: 16511933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloperoxidase in nasal secretion as a cell-activation marker in acute sinusitis.
    Haxel BR; Woywode C; Mewes T; Mann WJ
    Am J Rhinol; 2004; 18(2):93-8. PubMed ID: 15152874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment modalities for bacterial rhinosinusitis.
    Brook I
    Expert Opin Pharmacother; 2010 Apr; 11(5):755-69. PubMed ID: 20201730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interstitial pneumonitis associated with infliximab therapy.
    Villeneuve E; St-Pierre A; Haraoui B
    J Rheumatol; 2006 Jun; 33(6):1189-93. PubMed ID: 16622902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.